Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.
Identifieur interne : 000065 ( Main/Exploration ); précédent : 000064; suivant : 000066Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.
Auteurs : Varun Malhotra [États-Unis] ; Sandeep Magoon [États-Unis] ; Dean A. Troyer [États-Unis] ; Thomas R. Mccune [États-Unis]Source :
- Journal of investigative medicine high impact case reports [ 2324-7096 ]
Descripteurs français
- KwdFr :
- Acide ascorbique (administration et posologie), Acide ascorbique (effets indésirables), Adulte d'âge moyen (MeSH), Atteinte rénale aigüe (diagnostic), Atteinte rénale aigüe (étiologie), Betacoronavirus (MeSH), Biopsie (MeSH), Glomérule rénal (anatomopathologie), Glomérulonéphrite segmentaire et focale (diagnostic), Glomérulonéphrite segmentaire et focale (induit chimiquement), Humains (MeSH), Hyperoxalurie (diagnostic), Hyperoxalurie (induit chimiquement), Hyperoxalurie (métabolisme), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (épidémiologie), Injections veineuses (MeSH), Maladie aigüe (MeSH), Mâle (MeSH), Oxalates (métabolisme), Pandémies (MeSH), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (épidémiologie), Vitamines (administration et posologie), Vitamines (effets indésirables), Évolution de la maladie (MeSH).
- MESH :
- administration et posologie : Acide ascorbique, Vitamines.
- anatomopathologie : Glomérule rénal.
- diagnostic : Atteinte rénale aigüe, Glomérulonéphrite segmentaire et focale, Hyperoxalurie.
- effets indésirables : Acide ascorbique, Vitamines.
- induit chimiquement : Glomérulonéphrite segmentaire et focale, Hyperoxalurie.
- métabolisme : Hyperoxalurie, Oxalates.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- étiologie : Atteinte rénale aigüe.
- Adulte d'âge moyen, Betacoronavirus, Biopsie, Humains, Injections veineuses, Maladie aigüe, Mâle, Pandémies, Évolution de la maladie.
English descriptors
- KwdEn :
- Acute Disease (MeSH), Acute Kidney Injury (diagnosis), Acute Kidney Injury (etiology), Ascorbic Acid (administration & dosage), Ascorbic Acid (adverse effects), Betacoronavirus (MeSH), Biopsy (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Disease Progression (MeSH), Glomerulosclerosis, Focal Segmental (chemically induced), Glomerulosclerosis, Focal Segmental (diagnosis), Humans (MeSH), Hyperoxaluria (chemically induced), Hyperoxaluria (diagnosis), Hyperoxaluria (metabolism), Injections, Intravenous (MeSH), Kidney Glomerulus (pathology), Male (MeSH), Middle Aged (MeSH), Oxalates (metabolism), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), SARS-CoV-2 (MeSH), Vitamins (administration & dosage), Vitamins (adverse effects).
- MESH :
- chemical , administration & dosage : Ascorbic Acid, Vitamins.
- chemical , adverse effects : Ascorbic Acid, Vitamins.
- chemically induced : Glomerulosclerosis, Focal Segmental, Hyperoxaluria.
- diagnosis : Acute Kidney Injury, Glomerulosclerosis, Focal Segmental, Hyperoxaluria.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- etiology : Acute Kidney Injury.
- metabolism : Hyperoxaluria, Oxalates.
- pathology : Kidney Glomerulus.
- Acute Disease, Betacoronavirus, Biopsy, COVID-19, Disease Progression, Humans, Injections, Intravenous, Male, Middle Aged, Pandemics, SARS-CoV-2.
Abstract
As COVID-19 (coronavirus disease 2019) spreads across the world multiple therapeutic interventions have been tried to reduce morbidity and mortality. We describe a case of collapsing focal sclerosing glomerulosclerosis (FSGS) and acute oxalate nephropathy in a patient treated with high-dose intravenous vitamin C for severe COVID-19 infection. Collapsing FSGS has been described in patients with COVID-19 infection associated with APOL-1; however, this case had collapsing FSGS developing in low-risk heterozygous APOL-1 variant, and we postulate that the intensity of the COVID-19 cytokine storm overwhelmed the protective state of APOL-1 heterozygosity. This case illustrates the importance of assessing the risk and benefit of planned therapeutic interventions on a case-by-case basis especially when there are still so many unknowns in the management of COVID-19 infection. Strong consideration should be given for performing a renal biopsy in patients who develop multifactorial acute kidney injury.
DOI: 10.1177/2324709620963635
PubMed: 33019829
PubMed Central: PMC7543098
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.</title><author><name sortKey="Malhotra, Varun" sort="Malhotra, Varun" uniqKey="Malhotra V" first="Varun" last="Malhotra">Varun Malhotra</name><affiliation wicri:level="2"><nlm:affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Eastern Virginia Medical School, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Magoon, Sandeep" sort="Magoon, Sandeep" uniqKey="Magoon S" first="Sandeep" last="Magoon">Sandeep Magoon</name><affiliation wicri:level="2"><nlm:affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Eastern Virginia Medical School, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Troyer, Dean A" sort="Troyer, Dean A" uniqKey="Troyer D" first="Dean A" last="Troyer">Dean A. Troyer</name><affiliation wicri:level="2"><nlm:affiliation>Sentara Norfolk General Hospital, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Sentara Norfolk General Hospital, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Mccune, Thomas R" sort="Mccune, Thomas R" uniqKey="Mccune T" first="Thomas R" last="Mccune">Thomas R. Mccune</name><affiliation wicri:level="2"><nlm:affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Eastern Virginia Medical School, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Jan-Dec</date><idno type="RBID">pubmed:33019829</idno><idno type="pmid">33019829</idno><idno type="doi">10.1177/2324709620963635</idno><idno type="pmc">PMC7543098</idno><idno type="wicri:Area/Main/Corpus">000154</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000154</idno><idno type="wicri:Area/Main/Curation">000154</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000154</idno><idno type="wicri:Area/Main/Exploration">000154</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.</title><author><name sortKey="Malhotra, Varun" sort="Malhotra, Varun" uniqKey="Malhotra V" first="Varun" last="Malhotra">Varun Malhotra</name><affiliation wicri:level="2"><nlm:affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Eastern Virginia Medical School, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Magoon, Sandeep" sort="Magoon, Sandeep" uniqKey="Magoon S" first="Sandeep" last="Magoon">Sandeep Magoon</name><affiliation wicri:level="2"><nlm:affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Eastern Virginia Medical School, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Troyer, Dean A" sort="Troyer, Dean A" uniqKey="Troyer D" first="Dean A" last="Troyer">Dean A. Troyer</name><affiliation wicri:level="2"><nlm:affiliation>Sentara Norfolk General Hospital, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Sentara Norfolk General Hospital, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Mccune, Thomas R" sort="Mccune, Thomas R" uniqKey="Mccune T" first="Thomas R" last="Mccune">Thomas R. Mccune</name><affiliation wicri:level="2"><nlm:affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Eastern Virginia Medical School, Norfolk, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author></analytic><series><title level="j">Journal of investigative medicine high impact case reports</title><idno type="eISSN">2324-7096</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease (MeSH)</term><term>Acute Kidney Injury (diagnosis)</term><term>Acute Kidney Injury (etiology)</term><term>Ascorbic Acid (administration & dosage)</term><term>Ascorbic Acid (adverse effects)</term><term>Betacoronavirus (MeSH)</term><term>Biopsy (MeSH)</term><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (epidemiology)</term><term>Disease Progression (MeSH)</term><term>Glomerulosclerosis, Focal Segmental (chemically induced)</term><term>Glomerulosclerosis, Focal Segmental (diagnosis)</term><term>Humans (MeSH)</term><term>Hyperoxaluria (chemically induced)</term><term>Hyperoxaluria (diagnosis)</term><term>Hyperoxaluria (metabolism)</term><term>Injections, Intravenous (MeSH)</term><term>Kidney Glomerulus (pathology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Oxalates (metabolism)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (epidemiology)</term><term>SARS-CoV-2 (MeSH)</term><term>Vitamins (administration & dosage)</term><term>Vitamins (adverse effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acide ascorbique (administration et posologie)</term><term>Acide ascorbique (effets indésirables)</term><term>Adulte d'âge moyen (MeSH)</term><term>Atteinte rénale aigüe (diagnostic)</term><term>Atteinte rénale aigüe (étiologie)</term><term>Betacoronavirus (MeSH)</term><term>Biopsie (MeSH)</term><term>Glomérule rénal (anatomopathologie)</term><term>Glomérulonéphrite segmentaire et focale (diagnostic)</term><term>Glomérulonéphrite segmentaire et focale (induit chimiquement)</term><term>Humains (MeSH)</term><term>Hyperoxalurie (diagnostic)</term><term>Hyperoxalurie (induit chimiquement)</term><term>Hyperoxalurie (métabolisme)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Infections à coronavirus (épidémiologie)</term><term>Injections veineuses (MeSH)</term><term>Maladie aigüe (MeSH)</term><term>Mâle (MeSH)</term><term>Oxalates (métabolisme)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Pneumopathie virale (épidémiologie)</term><term>Vitamines (administration et posologie)</term><term>Vitamines (effets indésirables)</term><term>Évolution de la maladie (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Ascorbic Acid</term><term>Vitamins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Ascorbic Acid</term><term>Vitamins</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acide ascorbique</term><term>Vitamines</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Glomérule rénal</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Glomerulosclerosis, Focal Segmental</term><term>Hyperoxaluria</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Acute Kidney Injury</term><term>Glomerulosclerosis, Focal Segmental</term><term>Hyperoxaluria</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Atteinte rénale aigüe</term><term>Glomérulonéphrite segmentaire et focale</term><term>Hyperoxalurie</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Acide ascorbique</term><term>Vitamines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Acute Kidney Injury</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Glomérulonéphrite segmentaire et focale</term><term>Hyperoxalurie</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Hyperoxaluria</term><term>Oxalates</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Hyperoxalurie</term><term>Oxalates</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Kidney Glomerulus</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Atteinte rénale aigüe</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Betacoronavirus</term><term>Biopsy</term><term>COVID-19</term><term>Disease Progression</term><term>Humans</term><term>Injections, Intravenous</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Betacoronavirus</term><term>Biopsie</term><term>Humains</term><term>Injections veineuses</term><term>Maladie aigüe</term><term>Mâle</term><term>Pandémies</term><term>Évolution de la maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">As COVID-19 (coronavirus disease 2019) spreads across the world multiple therapeutic interventions have been tried to reduce morbidity and mortality. We describe a case of collapsing focal sclerosing glomerulosclerosis (FSGS) and acute oxalate nephropathy in a patient treated with high-dose intravenous vitamin C for severe COVID-19 infection. Collapsing FSGS has been described in patients with COVID-19 infection associated with APOL-1; however, this case had collapsing FSGS developing in low-risk heterozygous APOL-1 variant, and we postulate that the intensity of the COVID-19 cytokine storm overwhelmed the protective state of APOL-1 heterozygosity. This case illustrates the importance of assessing the risk and benefit of planned therapeutic interventions on a case-by-case basis especially when there are still so many unknowns in the management of COVID-19 infection. Strong consideration should be given for performing a renal biopsy in patients who develop multifactorial acute kidney injury.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33019829</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2324-7096</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><PubDate><MedlineDate>2020 Jan-Dec</MedlineDate></PubDate></JournalIssue><Title>Journal of investigative medicine high impact case reports</Title><ISOAbbreviation>J Investig Med High Impact Case Rep</ISOAbbreviation></Journal><ArticleTitle>Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.</ArticleTitle><Pagination><MedlinePgn>2324709620963635</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/2324709620963635</ELocationID><Abstract><AbstractText>As COVID-19 (coronavirus disease 2019) spreads across the world multiple therapeutic interventions have been tried to reduce morbidity and mortality. We describe a case of collapsing focal sclerosing glomerulosclerosis (FSGS) and acute oxalate nephropathy in a patient treated with high-dose intravenous vitamin C for severe COVID-19 infection. Collapsing FSGS has been described in patients with COVID-19 infection associated with APOL-1; however, this case had collapsing FSGS developing in low-risk heterozygous APOL-1 variant, and we postulate that the intensity of the COVID-19 cytokine storm overwhelmed the protective state of APOL-1 heterozygosity. This case illustrates the importance of assessing the risk and benefit of planned therapeutic interventions on a case-by-case basis especially when there are still so many unknowns in the management of COVID-19 infection. Strong consideration should be given for performing a renal biopsy in patients who develop multifactorial acute kidney injury.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malhotra</LastName><ForeName>Varun</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magoon</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troyer</LastName><ForeName>Dean A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-0337-5890</Identifier><AffiliationInfo><Affiliation>Sentara Norfolk General Hospital, Norfolk, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCune</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Eastern Virginia Medical School, Norfolk, VA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Investig Med High Impact Case Rep</MedlineTA><NlmUniqueID>101624758</NlmUniqueID><ISSNLinking>2324-7096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010070">Oxalates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005923" MajorTopicYN="N">Glomerulosclerosis, Focal Segmental</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006959" MajorTopicYN="N">Hyperoxaluria</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007678" MajorTopicYN="N">Kidney Glomerulus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010070" MajorTopicYN="N">Oxalates</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">AKI</Keyword><Keyword MajorTopicYN="Y">COVID</Keyword><Keyword MajorTopicYN="Y">FSGS</Keyword><Keyword MajorTopicYN="Y">SARS</Keyword><Keyword MajorTopicYN="Y">collapsing</Keyword><Keyword MajorTopicYN="Y">glomerulopathy</Keyword><Keyword MajorTopicYN="Y">oxalate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33019829</ArticleId><ArticleId IdType="doi">10.1177/2324709620963635</ArticleId><ArticleId IdType="pmc">PMC7543098</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kidney Int Rep. 2018 Jul 29;3(6):1363-1372</Citation><ArticleIdList><ArticleId IdType="pubmed">30450463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2020 Apr 28;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32346659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2017 Jun;151(6):1229-1238</Citation><ArticleIdList><ArticleId IdType="pubmed">27940189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2020 Oct;5(10):1815-1822</Citation><ArticleIdList><ArticleId IdType="pubmed">32838081</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2019 Oct 1;322(13):1261-1270</Citation><ArticleIdList><ArticleId IdType="pubmed">31573637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2020 Apr 09;5(6):935-939</Citation><ArticleIdList><ArticleId IdType="pubmed">32292867</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2013 Mar;8(3):399-406</Citation><ArticleIdList><ArticleId IdType="pubmed">23220425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Med. 2020 Jun 07;2(4):488-492</Citation><ArticleIdList><ArticleId IdType="pubmed">32775989</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1985 May;145(5):950-1</Citation><ArticleIdList><ArticleId IdType="pubmed">3994472</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Virginie</li></region></list><tree><country name="États-Unis"><region name="Virginie"><name sortKey="Malhotra, Varun" sort="Malhotra, Varun" uniqKey="Malhotra V" first="Varun" last="Malhotra">Varun Malhotra</name></region><name sortKey="Magoon, Sandeep" sort="Magoon, Sandeep" uniqKey="Magoon S" first="Sandeep" last="Magoon">Sandeep Magoon</name><name sortKey="Mccune, Thomas R" sort="Mccune, Thomas R" uniqKey="Mccune T" first="Thomas R" last="Mccune">Thomas R. Mccune</name><name sortKey="Troyer, Dean A" sort="Troyer, Dean A" uniqKey="Troyer D" first="Dean A" last="Troyer">Dean A. Troyer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidVariantV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000065 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000065 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidVariantV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33019829
|texte= Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33019829" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidVariantV1
| This area was generated with Dilib version V0.6.38. |  |